ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

LAZARD ASSET MANAGEMENT LLC's Holding History (CIK: 0001207017)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 980,000 Value ($000) $16 Avg Close — Range —
Q2 2025
Shares 54,618,000 Value ($000) $71 Avg Close — Range —
Q1 2025
Shares 44,423,000 Value ($000) $51 Avg Close — Range —
Q4 2024
Shares 48,085,000 Value ($000) $51 Avg Close — Range —
Q3 2024
Shares 58,777,000 Value ($000) $69 Avg Close — Range —
Q2 2024
Shares 60,423,000 Value ($000) $65 Avg Close — Range —
Q1 2024
Shares 60,423,000 Value ($000) $57 Avg Close — Range —
Q4 2023
Shares 29,539,000 Value ($000) $29 Avg Close — Range —